New pill shows promise for gut disease relief

NCT ID NCT05486104

First seen Apr 06, 2026 · Last updated May 13, 2026 · Updated 5 times

Summary

This study tests a new drug called Hemay005 in people with moderate to severe ulcerative colitis, a condition causing inflammation in the colon. About 92 adults will receive either a low dose, high dose, or a placebo for 12 weeks. The goal is to see if the drug can reduce symptoms like diarrhea and bleeding and help the gut heal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Chaoyang Hospital Affiliated to Capital Medical University

    Beijing, China

  • Beijing Friendship Hospital Affiliated to Capital Medical University

    Beijing, China

  • Chongqing People's Hospital

    Chongqing, China

  • First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Peking University Third Hospital

    Beijing, China

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

  • Shandong Provincial Hospital

    Jinan, Shandong, China

  • Shanghai Oriental Hospital

    Shanghai, China

  • Shengjing Hospital Affiliated to China Medical University

    Shenyang, Liaoning, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • The Fourth Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • The Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Tianjin Medical University General Hospital

    Tianjin, China

  • Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China

Conditions

Explore the condition pages connected to this study.